查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1449296

全球獸用AP（活性藥物成分）市場市場：份額、規模、趨勢、行業分析報告- 按服務類型、按合成類型、按動物類型、按治療類別、按地區、細分市場預測，2024 -2032 年

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type ; By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

到2032年，全球獸用API（活性藥物成分）製造市場規模預計將達到146.3億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

獸用原料藥是獸藥的重要組成部分。 這些成分負責產生所需的治療效果，並在批准用於商業用途之前經過嚴格的測試和研究。 隨著動物保健解決方案的需求不斷增加，高品質獸用原料藥市場也蓬勃發展。 由於多種因素的影響，該市場預計將成長，包括獸藥研發、外包、設施擴建和動物保健支出增加的投資。

動物 API 市場是由外包 API 製造的營運和成本效益優勢所驅動的。 動物保健公司正在積極尋求優化營運和降低成本的方法。 透過將獸用原料藥生產外包給專業製造商，製藥公司可以專注於其核心優勢，例如研發、行銷和分銷。 在人們日益認識到動物健康和福利的重要性的推動下，這一趨勢導致了動物 API 市場的顯著擴張。

由於跨境感染和人畜共通傳染病的日益流行，獸用 AP 市場正在經歷顯著增長。 這些疾病對動物和人類都構成重大風險，並且可以迅速跨境傳播，對公共衛生、全球貿易和動物福利構成威脅。 獸用原料藥的使用對於控制和預防這些疾病的傳播變得極為重要。 獸藥在治療受影響的動物、制定有效的治療策略以及減輕症狀的嚴重程度以幫助受影響的動物康復方面發揮著至關重要的作用。 動物原料藥製造業高度多樣化，滿足不同動物物種的多樣化健康需求。 它由眾多公司組成，從大型跨國製藥公司到中型公司。

動物 API 製造市場報告重點

該市場由自有製造部門主導，主要是因為存在許多大型獸藥製造商，他們建立了自己的原料藥生產設施。 這項策略措施確保了供應鏈不間斷，並嚴格控制產品品質。

在評估期間，動物 API 製造市場預計生物 API 產業將顯著成長。 這種增長是由動物保健領域對先進生物製品和疫苗的需求不斷增長所推動的。

2023年，抗感染產業是全球獸用原料藥製造市場的最大貢獻者。 這是因為對治療動物細菌、真菌和病毒感染的抗生素和其他抗菌劑的需求量很大。

2023年的全球市場以北美地區為主，這主要是由於美國和加拿大等國家已經建立了動物保健產業。 這些產業的存在導致對動物原料藥的高需求，使北美成為動物原料藥的最大市場。

目錄

第1章簡介

第 2 章執行摘要

第3章研究方法

第 4 章全球動物 API 製造市場洞察

  • 動物 API 製造 - 產業概況
  • 動物 API 製造 - 市場動態
    • 推動者和機會
    • 抑制因素和挑戰
  • 杵分析
  • 動物原料藥製造業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球動物 API 製造市場：依服務類型

  • 主要發現
  • 簡介
  • 內部
  • 合約工作外包

第 6 章全球動物 API 製造市場：依合成類型

  • 主要發現
  • 簡介
  • 生物原料藥
  • 基於化學的 API
  • HPAPI

第 7 章全球動物原料藥製造市場：依治療類別

  • 主要發現
  • 簡介
  • 驅蟲藥
  • 抗感染藥物
  • 非類固醇抗發炎藥
  • 其他

第 8 章全球動物 API 製造市場：依動物類型

  • 主要發現
  • 簡介
  • 生產動物
  • 伴侶動物

第 9 章按地區劃分的全球動物 API 製造市場

  • 主要發現
  • 簡介
    • 動物 API 製造市場評估：按地區（2019-2032 年）
  • 動物 API 製造市場 - 北美
    • 依服務類型
    • 依動物類型
    • 依成分型
    • 依治療類別
    • 美國
    • 加拿大
  • 動物 API 製造市場 - 歐洲
    • 依服務類型
    • 依動物類型
    • 依成分型
    • 依治療類別
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 動物 API 製造市場 - 亞太地區
    • 依服務類型
    • 依動物類型
    • 依成分型
    • 依治療類別
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
  • 動物 API 製造市場 - 中東和非洲
    • 依服務類型
    • 依動物類型
    • 依成分型
    • 依治療類別
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿聯酋
  • 動物 API 製造市場 - 拉丁美洲
    • 依服務類型
    • 依動物類型
    • 依成分型
    • 依治療類別
    • 墨西哥
    • 巴西
    • 阿根廷

第10章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第11章公司簡介

  • Alivira Animal Health Ltd.
  • Chempro Pharma Pvt. Ltd
  • Elanco
  • Excel Industries Ltd.
  • MENADIONA
  • Ofichem Group
  • Qilu Animal Health Products Co., Ltd.
  • Siflon Drugs
  • SUANFARMA
  • Vetpharma
  • Zoetis
Product Code: PM4540

The global Veterinary Active Pharmaceutical Ingredients Manufacturing market size is expected to reach USD 14.63 Billion by 2032, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Service Type (In House, Contract Outsourcing); By Synthesis Type; By Animal Type; By Therapeutic Category; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (APIs) are essential components of animal medicines. These ingredients are responsible for producing the desired therapeutic effects and undergo rigorous testing and research before they are approved for commercial use. As the demand for animal healthcare solutions continues to increase, the market for high-quality veterinary APIs is also growing rapidly. The market is anticipated to grow owing to numerous factors such as research & development of veterinary products, increasing investment in outsourcing, facility expansion, and expenditure on animal health.

The veterinary active pharmaceutical ingredient (API) market has been driven by the operational and cost-effectiveness benefits of outsourcing the manufacturing of APIs. Animal health companies are actively seeking ways to optimize their operations and reduce costs. By outsourcing the production of veterinary APIs to specialized manufacturers, pharmaceutical companies can focus on their core strengths, including research, development, marketing, and distribution. This trend has led to a significant expansion in the veterinary API market, driven by a growing awareness of the importance of animal health and welfare.

The market for veterinary active pharmaceutical ingredients (APIs) is witnessing significant growth owing to the rising prevalence of transboundary and zoonotic diseases. These diseases pose a significant risk to both animal and human populations and can spread rapidly across borders, posing a threat to public health, global trade, and animal welfare. The use of veterinary APIs has become crucial in controlling and preventing the spread of these diseases. They play a pivotal role in treating diseased animals, developing effective treatment strategies, and reducing the severity of symptoms, which aids in the recovery of affected animals. The veterinary API manufacturing sector is highly diverse and caters to the varied health needs of different animal species. It comprises a broad spectrum of companies ranging from large multinational pharmaceutical corporations to mid-sized enterprises.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

The market is dominated by the in-house segment, mainly due to the presence of numerous leading animal health companies that have set up their own API manufacturing facilities. This strategic move has helped them ensure an uninterrupted supply chain and maintain strict control over the quality of their products.

The veterinary API manufacturing market is projected to witness substantial growth in the biological API segment in the assessment period. This growth can be attributed to the rising need for advanced biologics and vaccines for animal healthcare.

In 2023, the global market for manufacturing veterinary active pharmaceutical ingredients (API) had the anti-infective segment as the largest contributor. This was due to the significant demand for antibiotics and other anti-microbial agents to treat bacterial, fungal, and viral infections in animals.

The global market in 2023 was dominated by the North American region, primarily due to the well-established animal healthcare industries in countries such as the United States and Canada. The presence of these industries has resulted in a high demand for veterinary APIs, making North America the largest market for veterinary APIs.

The global key market players include Alivira Animal Health Ltd., Chempro Pharma Pvt. Ltd., Elanco, Excel Industries Ltd., MENADIONA, Ofichem Group, Qilu Animal Health Products Co., Ltd., Siflon Drugs, SUANFARMA, Vetpharma, Zoetis, and among others.

Polaris Market Research has segmented the Veterinary Active Pharmaceutical Ingredients Manufacturing market report based on service type, synthesis type, animal type, therapeutic category, and region:

Veterinary Active Pharmaceutical Ingredients Manufacturing, Service Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • In House
  • Contract Outsourcing
  • Contract Development
  • Preclinical Development
  • Clinical Development
  • Contract Manufacturing

Veterinary Active Pharmaceutical Ingredients Manufacturing, Synthesis Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Biological API
  • Chemical-based API
  • HPAPI

Veterinary Active Pharmaceutical Ingredients Manufacturing, Animal Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Production Animals
  • Companion Animals

Veterinary Active Pharmaceutical Ingredients Manufacturing, Therapeutic Category Outlook (Revenue - USD Billion, 2019 - 2032)

  • Antiparasitic
  • Anti-infectives
  • NSAIDs
  • Others

Veterinary Active Pharmaceutical Ingredients Manufacturing, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

  • 4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing - Industry Snapshot
  • 4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing prevalence of transboundary and zoonotic diseases fuels veterinary active pharmaceutical ingredients manufacturing market growth
      • 4.2.1.2. The cost-effectiveness and operational advantages of outsourcing API manufacturing drives market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The high cost of veterinary diagnostic and treatment hampers veterinary active pharmaceutical ingredients manufacturing market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • 5.3. In-house
    • 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In-house, by Region, 2019-2032 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2019-2032 (USD Billion)
    • 5.4.2. Contract Development
      • 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2019-2032 (USD Billion)
      • 5.4.2.2 Preclinical Development
      • 5.4.2.21. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2019-2032 (USD Billion)
      • 5.4.2.3 Clinical Development
      • 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2019-2032 (USD Billion)
    • 5.4.3. Contract Manufacturing
      • 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2019-2032 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • 6.3. Biological API
    • 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2019-2032 (USD Billion)
  • 6.4. Chemical-based API
    • 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2019-2032 (USD Billion)
  • 6.5. HPAPI
    • 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2019-2032 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 7.3. Antiparasitic
    • 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitic, by Region, 2019-2032 (USD Billion)
  • 7.4. Anti-infectives
    • 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
  • 7.5. NSAIDs
    • 7.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • 8.3. Production Animals
    • 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2019-2032 (USD Billion)
  • 8.4. Companion Animals
    • 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2019-2032 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
    • 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - U.S.
      • 9.3.5.1. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
      • 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
    • 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
      • 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
      • 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
      • 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
      • 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
      • 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
      • 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
      • 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
      • 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
      • 9.5.7.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
      • 9.5.8.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
      • 9.6.6.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
      • 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
      • 9.6.8.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • 9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
    • 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
    • 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alivira Animal Health Ltd.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Chempro Pharma Pvt. Ltd
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Elanco
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Excel Industries Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. MENADIONA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Ofichem Group
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Qilu Animal Health Products Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Siflon Drugs
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. SUANFARMA
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Vetpharma
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Zoetis
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development

List of Tables

  • Table 1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, by Region, 2019-2032 (USD Billion)
  • Table 5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 7 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 8 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 9 North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 11 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 13 U.S.: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 14 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 15 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 17 Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 18 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 19 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 21 Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 22 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 25 Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 26 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 27 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 28 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 29 France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 30 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 31 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 32 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 33 UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 34 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 35 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 37 Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 42 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 43 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 45 Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 46 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 47 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 49 Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 54 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 55 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 56 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 57 China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 58 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 59 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 61 Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 62 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 63 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 64 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 65 India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 74 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 75 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 77 South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 78 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 79 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 81 Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 83 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 85 Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 86 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 87 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 89 Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 90 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 91 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 93 Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 98 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 99 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 101 UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 106 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 107 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 109 South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)
  • Table 110 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2019-2032 (USD Billion)
  • Table 111 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2019-2032 (USD Billion)
  • Table 113 Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Animal Type
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Service Type
  • Figure 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Animal Type
  • Figure 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Synthesis Type
  • Figure 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Therapeutic Category
  • Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2021 & 2030 (USD Billion)